Where Leading Physicians, Scientists & Experts Share their Wisdom about Psychedelic Medicines and Healing
Your single source of truth for
the psychedelic news.
Start your journey with Episode 1 today!
Instagram: @DrDavidRabin
Dr. Dave Rabin MD, PhD, a board-certified psychiatrist and neuroscientist trained in Ketamine and MDMA-assisted therapy, brings you the newest developments from the psychedelic world. From researchers and investors to physicians and shamans to nonprofit pioneers and policy-makers — each week, Dr. Dave brings you the latest news and answers your questions to share perspectives from the front lines of this exciting movement.
Our mission is to share the latest knowledge from medical and scientific research with the public to enhance safety, education, awareness, and access to the rapidly evolving field of psychedelic medicine.
With your host Dr. Dave Rabin MD, PhD
Dr. Dave is a psychiatrist, neuroscientist, entrepreneur & inventor who has been studying the impact of chronic stress in humans for over 15 years. His research has focused on evaluating minimally-invasive therapies, such as wearables and psychedelic-assisted therapy, for treatment-resistant illnesses such as PTSD and depression. He is the co-founder & Chief Medical Officer at Apollo Neuroscience and the Executive Director of The Board of Medicine.
In addition to his clinical psychiatry practice , Dr. Rabin is currently conducting research with MAPS on the epigenetic regulation of trauma responses and recovery to improve our understanding of the mechanisms of psychedelic-assisted therapy.
He received his MD in medicine and PhD in neuroscience from Albany Medical College and specialized in psychiatry with a distinction in research at the University of Pittsburgh Medical Center. Dr. Rabin is a practitioner of ketamine-assisted psychotherapy and is trained in MDMA-assisted therapy.
@Dr. Dave
Featuring Special Guests Including

Paul Austin is the Founder of Synthesis & The Third Wave

Joe Green is the co-founder and President of Psychedelic Science Funders Collaborative (PSFC). Joe and Tim Ferriss are spearheading the research and commercialization of MDMA with Rick Doblin and MAPS on the Capstone Project to make MDMA a medicine.

Jenny Stefanotti is the founder and principal of Dent, an advisory practice passionate about addressing big challenges; such as climate change, the incentives of capitalism, and the ethics of the technology industry.

Dr. Phil Wolfson is a practicing psychiatrist, research scientist, mentor, pioneer of psychedelic psychotherapy, and founder of the practice of Ketamine Assisted Psychotherapy. He has trained hundreds of people to practice Ketamine Assisted Psychotherapy, which is currently the only legal form of psychedelic medicine available in most countries around the world.

Tim Ferriss has been listed as one of Fast Company’s “Most Innovative Business People” and one of Fortune’s “40 under 40.” He is an early-stage technology investor/advisor (Uber, Facebook, Shopify, Duolingo, Alibaba, and 50+ others) and the author of five #1 New York Times and Wall Street Journal bestsellers, including The 4-Hour Workweek and Tools of Titans: The Tactics, Routines, and Habits of Billionaires, Icons, and World-Class Performers. The Tim Ferriss Show podcast is the first business/interview podcast to exceed 100 million downloads. Tim is a funding pioneer in the psychedelic research space.

Liana Sananda Gillooly is the Development Officer at the Multidisciplinary Association for Psychedelic Studies (MAPS). Her role is to build awareness of this emergent movement in psychiatry and to fundraise for this groundbreaking research. Liana is also a change maker in the transformational technology movement, with an interest in VR/AR therapy and emergent blockchain technologies.

Tim Chang is a partner at The Mayfield Fund, focusing on venture capital invests in Consumer Internet, Digital Media, eCommerce/Marketplaces and Health/Wellness. He has been twice named on the Midas List of top 100 VCs. Tim led Mayfield's investments resulting in a number of successful exits and is one of the key folks leads the charge of conscious capital. In this episode we will take a deep dive into the world of conscious investing and psychedelics. Tim is also a co-founder and board member of Auryn/North Star, the ethical trade association for the psychedelic medicine industry.

Described by Men's Health described as a "lifestyle guru”, Dave the founder of Bulletproof and Upgrade Labs. Dave is a passionate pioneer of human optimization and has developed and supported numerous products since 2013. Both Dr. Dave and Dr. Molly have been featured on Dave Asprey’s award-winning podcast Bulletproof Radio.

Jackee Stang is the President and Founder of Delic Corp, the first-ever psychedelic wellness corporation. Delic aims to re-frame the psychedelic conversation and open the doors of civil discourse to a mainstream audience. We are tastemakers designing filters for a psychedelic lifestyle. Before working as the VP of Content at High Times, Jackee was an award winning producer for Bulletproof Radio, and a multi-million fundraiser for the Catholic Church in Texas. You could call her the psychedelic cowgirl.

Kathryn Fantauzzi is the co-founder & CEO of Apollo Neuroscience, the company that developed and launched the first scientifically-validated wearable technology that actively improves energy, focus, sleep, & heart rate variability. Dedicated to innovation with a passion for tech transfer and public/private partnerships, Kathryn believes in getting good science out of the lab and into people’s lives.

Dr. Emmanuelle Schindler MD, PhD is a board-certified Neurologist at Yale School of Medicine and has expertise in headache medicine. She has developed and executed the first controlled trials investigating the effects and mechanisms of psilocybin in headache disorders. Dr. Schindler studied the neuropharmacology of psychedelics and other serotonergic compounds in the context of receptor binding and intracellular signaling.

James Keim is the CEO of MIMOSA Therapeutics, a company that creates medical-grade, natural psychedelics for clinicians and researchers. James is a psychotherapist experienced with psychedelic medicines and co-author of the book, The Violence of Men. He directed a small conference series on systems issues in human health that was hosted at the Bethesda Campus of the National Institutes of Health and has served as an invited participant in the Best Pharmaceuticals for Children Act collaboration conferences at NIH for over a decade.

Rick Doblin is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS) with the goal of making MDMA an FDA-approved medicine. Aside from giving one of the best TED Talks ever, Rick is a pioneer of the psychedelic medicine movement, and has been the force of nature behind ushering MDMA, cannabis, and other powerful medicines into mainstream health practice.

John Cammack is an impact investor and entrepreneur, managing partner at Kingcedar Holdings, partner at Bridge Builders Collaborative, and an overall visionary in the health, wellbeing, and mindfulness investment arenas. As a mover and shaker, angel investor, and social innovator in enterprises and technologies advancing brain fitness, educational attainment and behavioral change, John joins us to discuss the future of ethical investments in the psychedelic space.

Christo is a platinum-selling Grammy-nominated producer, composer, and DJ from Pittsburgh. He’s known best for his work with Dreamville artists such as J.I.D and J. Cole. Join us for a discussion on the influence of psychedelics in hip-hop.

Dr. Joseph Barsuglia PhD is an expert in Ibogaine and 5-MEO-DMT as well as in treating substance use disorders and severe PTSD in Veterans. Join us for an invigorating conversation on two of the most powerful psychedelic medicines known and how they can change the lives of people suffering from these debilitating chronic conditions.

Brian Muraresku is a lawyer and the acclaimed author of the New York Times bestseller The Immortality Key, debuting at #10 in November. In December, Audible named it Best of 2020 in the History category. After the launch on Joe Rogan, Muraresku appeared on CNN, NPR and Andrew Sullivan's podcast. And has now been featured in Forbes, Daily Beast, Big Think and VICE.

Dr. Belinda Tan MD, PhD and Dr. Noah Craft MD, PhD are founders of People Science, a direct-to-consumer scientific research company providing a scaled R&D platform for plant-based and natural medicines. The company is dedicated to the public good and is poised to revolutionize the alternative medicine landscape by empowering patients, consumers, providers, and scientists to collectively improve health outcomes.

SGT(R) Jonathan Lubecky served in both the Marines (95-99) and the US Army (03-09) deploying to Iraq 05-06. He was Medically Retired in 2009 due to a head injury and crippling PTSD that ultimately lead to 5 suicide attempts and hospitalizations. In 2014 he participated in a clinical trial exploring MDMA assisted psychotherapy which healed his PTSD. He currently works in Governmental Affairs for the psychedelic community.

Dylan Beynon is the Founder & CEO of Mindbloom, a mental health and wellbeing brand helping people achieve personal and clinical breakthroughs with clinician-prescribed psychedelic therapies. There, he is on a mission to transform lives to transform the world by increasing access to science-backed treatments, starting by lowering the cost of ketamine therapy for depression and anxiety by over 75%. Dylan is a 3x tech entrepreneur with both $100M+ in funding and an exit in his prior startups, which were focused on increasing access to justice and democracy. Dylan graduated from The Wharton Business School.

Dionisio Santos is an indigenous plant medicine expert, co-founder of TAKIWASI, and long-time practitioner of South American shamanism. Join us for a discussion of ancient plant medicine practices and how they are integrating into society at large.

Sara Gael is the Harm Reduction Officer at MAPS Zendo Project and a MAPS-trained MDMA-assisted psychotherapist in the FDA Phase III clinical trial. Join us as we discuss everything you need to know for the best safest psychedelic experiences, how to work through tough trips, and how to optimize set and setting for success.
Luke Storey is a motivational speaker, kundalini yoga and meditation teacher, world-class biohacker, host of The Life Stylist Podcast, and founder of the world's premier online fashion school for stylists, School of Style which he founded in 2008. Luke joins us to discuss the future of mental health, biohacking, and how he used psychedelic medicines to support health, wellbeing and sobriety.

March 12, 2021: Dr. James Fadiman PhD is a psychologist and writer who is acclaimed for his extensive work in the field of psychedelic research and specifically, microdosing. He co-founded along with Robert Frager the Institute of Transpersonal Psychology, which later became Sofia University, where he was a lecturer in psychedelic studies.

April 2, 2021: Leila Steinberg is a manager, business woman, educator, writer, poet, and founder of AIM4TheHeART, a 501(c)(3) non-profit dedicated to helping at-risk youth find their voice using an emotional literacy curriculum and writing workshops. She is best known as the artist mentor and first manager for superstar rapper Tupac Shakur. They met when he was a student in her writing workshop, The Microphone Sessions, in the Oakland Bay area. Today Leila manages the rapper Earl Sweatshirt, formerly of Odd Future.

April 9, 2021: Ariel Garten is an artist, scientist and intellectual known for integrating art and science. She is also the Chief Evangelist Officer and co-founder of InteraXon, developers of the MUSE Headband. Ariel lectures about interdisciplinary neuroscience topics, such as "The Neuroscience of Morals" (on TVO's Big Ideas televised lecture series), "The Neuroscience of Molecular Gastronomy" and others), as well as psychotherapy and mental health.

April 16, 2021: Nanea Reeves is the CEO & Co-Founder of TRIPP, a new start-up focused on creating mood altering experiences in VR. Prior to founding TRIPP, Nanea was President & COO of TextPlus, one of the top mobile communications applications on iOS and Android platforms.

April 23, 2021: Tricia Eastman and Dr. Joseph Barsuglia PhD cofacilitate retreats internationally as founders of Psychedelic Journeys facilitating Iboga and 5 MeO-DMT in destinations like Tulum, Ibiza, and Costa Rica. Tricia and Joseph have been initiated into Bwiti traditions of Fang and Ngonde Missoko tradition, as well as both worked for Crossroads Treatment Center in Mexico.

March 26, 2021: Dr. Diva Nagula is a board-certified osteopathic physician and has extensive knowledge and training in Integrative and Functional Medicine as well as psychedelic-assisted psychotherapy. A Washington, D.C. native, he grew up in Alexandria, Virginia. His interest in medicine developed at an early age when he decided to follow in his father’s footsteps and practice medicine. He is also the author of the best-seller “From Doctor to Patient”.

March 5, 2021: Victor Mifsud is an optimal health coach, citizen scientist, motivational speaker, and a documentary filmmaker. He has recently completed a feature-length documentary called My Neuroplastic Adventure. His journeys take him from the cutting edge of neuroscience to the most ancient forms of tribal healing.

February 5, 2021 & April 30, 2021: Jamie Wheal is the author of the global best-seller and Pulitzer Prize-nominated "Stealing Fire: How Silicon Valley, Navy SEALs and Maverick Scientists are Revolutionizing the Way We Live and Work" and the founder of the Flow Genome Project, an international organization dedicated to the research and training of ultimate human performance. Since founding the organization in 2011, it has gone on to become the leading voice of evidence-based peak performance in the world, counting award-winning academics, legendary professional athletes, special operations commanders, and Fortune 500 business leaders among the hundreds of thousands of people in its global community. On April 30, we will discuss his brand new book, "Recapture the Rapture: Rethinking God, Sex, and Death in a World That's Lost Its Mind".

February 19, 2021: Alexander Beiner is the co-founder of Rebel Wisdom, a media platform hosting nuanced conversations about transformative ideas in culture, psychology and philosophy. He's also a director of Breaking Convention; Europe's largest conference on psychedelic medicine and culture.

February 26, 2021: Steve DeAngelo is a globally recognized cannabis leader who was dubbed “the father of the legal industry” by former Speaker of the California Assembly Willie Brown. He is also the co-founder of the Last Prisoner Project (LPP), a nonprofit organization dedicated to cannabis criminal justice reform. LPP was founded out of the belief that if anyone is able to profit and build wealth in the legal cannabis industry, those individuals must also work to release and rebuild the lives of those who have suffered from cannabis criminalization. From grassroots community campaigns to appearing on national television networks and every uphill battle for legalization in between, his trailblazing work and creation of a model medical cannabis dispensary that set best practices for an entire industry make him one of the world's top cannabis experts, foremost thought leaders, and recognized entrepreneurs.

February 12, 2021: Rachel Yehuda, PhD, Professor of Psychiatry and Neuroscience, is the Director of the Center for Psychedelic Psychotherapy and Trauma Research. She is also Director of the Traumatic Stress Studies Division at the Mount Sinai School of Medicine which includes the PTSD clinical research program and the Neurochemistry and Neuroendocrinology laboratory at the James J. Peters Veterans Affairs Medical Center. Dr. Yehuda is a recognized leader in the field of traumatic stress studies. She has authored more than 450 published papers, chapters, and books in the field of traumatic stress and the neurobiology of PTSD. Her current interests include the study of risk and resilience factors, psychological and biological predictors of treatment response in PTSD, genetic and epigenetic studies of PTSD and the intergenerational transmission of trauma and PTSD. She has an active federally-funded clinical and research program that welcomes local and international students and clinicians.
